Sofalcone inhibits osteoclastogenesis through Keap1/Nrf2 signaling activation and mitigates ovariectomy-induced bone loss
International Immunopharmacology · 2025-12 · 166 · 115589
DOI: 10.1016/j.intimp.2025.115589 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-12. Verfasst von Haibo Liang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Spine Surgery, Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, W…. Hauptthemen laut MEDLINE: Kelch-Like ECH-Associated Protein 1, Osteoclasts, Osteoporosis, Bone Resorption. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Basic Research Project of Wenzhou City, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Spine Surgery, Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; School of the Second Clinical Medical Sciences, Wenzhou…
- School of the Second Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, China.
- Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; School of the Second Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, China. Electronic address: jiake.xu@siat.ac.c…
Förderung
- Basic Research Project of Wenzhou City
- National Natural Science Foundation of China
Zitieren
APA
Liang, H., Wu, Q., Hua, T., Chen, Y., Luo, J., Miao, J., Su, H., Yang, S., Xu, J., Wang, X., & Jin, H. (2025). Sofalcone inhibits osteoclastogenesis through Keap1/Nrf2 signaling activation and mitigates ovariectomy-induced bone loss. International Immunopharmacology, 166, 115589. https://doi.org/10.1016/j.intimp.2025.115589
Vancouver
Liang H, Wu Q, Hua T, Chen Y, Luo J, Miao J, et al. Sofalcone inhibits osteoclastogenesis through Keap1/Nrf2 signaling activation and mitigates ovariectomy-induced bone loss. International Immunopharmacology. 2025;166:115589. doi:10.1016/j.intimp.2025.115589
BibTeX
@article{Liang2025,
author = {Liang, Haibo and Wu, Qihang and Hua, Tianyong and Chen, Yiqi and Luo, Jiangtao and Miao, Jiansen and Su, Hong and Yang, Shu and Xu, Jiake and Wang, Xiangyang and Jin, Haiming},
title = {Sofalcone inhibits osteoclastogenesis through Keap1/Nrf2 signaling activation and mitigates ovariectomy-induced bone loss},
journal = {International Immunopharmacology},
year = {2025},
volume = {166},
pages = {115589},
doi = {10.1016/j.intimp.2025.115589}
}
EUVIMED